Pyrazino[1,2-b]isoquinolines: synthesis and study of their cytostatic and cytotoxic properties.

[1]  S. Danishefsky,et al.  Synthesis and cytotoxic evaluation of some cribrostatin-ecteinascidin analogues. , 2008, Journal of natural products.

[2]  Robert M. Williams,et al.  Antitumor activity of tetrahydroisoquinoline analogues 3-epi-jorumycin and 3-epi-renieramycin G. , 2006, Bioorganic & medicinal chemistry letters.

[3]  Zhanzhu Liu,et al.  Synthesis and antitumor activity of simplified ecteinascidin-saframycin analogs. , 2006, Bioorganic & medicinal chemistry letters.

[4]  Robert M. Williams,et al.  Asymmetric total syntheses of (-)-jorumycin, (-)-renieramycin G, 3-epi-jorumycin, and 3-epi-renieramycin G. , 2005, Journal of the American Chemical Society.

[5]  C. Avendaño,et al.  Synthesis of phthalascidin analogs , 2005 .

[6]  S. Danishefsky,et al.  Total synthesis of cribrostatin IV: fine-tuning the character of an amide bond by remote control. , 2005, Journal of the American Chemical Society.

[7]  C. Avendaño,et al.  Improvements in Aldol Reactions with Diketopiperazines , 2004 .

[8]  Michel Nussenzweig,et al.  H2AX: the histone guardian of the genome. , 2004, DNA repair.

[9]  C. Avendaño,et al.  Pictet Spengler-type reactions in 3-arylmethylpiperazine-2,5-diones. Synthesis of pyrazinotetrahydroisoquinolines , 2004 .

[10]  I. Turchi,et al.  Cyclizations of N-acyliminium ions. , 2004, Chemical reviews.

[11]  P. Cozzi,et al.  Recent anticancer cytotoxic agents. , 2004, Current medicinal chemistry. Anti-cancer agents.

[12]  Natividad Rodríguez,et al.  Synthesis of natural ecteinascidins (ET-729, ET-745, ET-759B, ET-736, ET-637, ET-594) from cyanosafracin B. , 2003, The Journal of organic chemistry.

[13]  G. Schwartsmann,et al.  Marine-derived anticancer agents in clinical trials , 2003, Expert opinion on investigational drugs.

[14]  C. Avendaño,et al.  Short stereocontrolled synthesis of trans and cis-tetrahydro-pyrazinoisoquinolinediones , 2003 .

[15]  Robert M. Williams,et al.  Synthetic studies on ecteinascidin-743: constructing a versatile pentacyclic intermediate for the synthesis of ecteinascidins and saframycins. , 2003, Organic Letters.

[16]  A. Myers,et al.  A solid-supported, enantioselective synthesis suitable for the rapid preparation of large numbers of diverse structural analogues of (-)-saframycin A. , 2002, Journal of the American Chemical Society.

[17]  R. Mantovani,et al.  Unique features of the mode of action of ET-743. , 2002, The oncologist.

[18]  Robin M. Williams,et al.  Chemistry and biology of the tetrahydroisoquinoline antitumor antibiotics. , 2002, Chemical reviews.

[19]  J. Mendieta,et al.  A 3.(ET743)-DNA complex that both resembles an RNA-DNA hybrid and mimicks zinc finger-induced DNA structural distortions. , 2002, Journal of medicinal chemistry.

[20]  S. Danishefsky,et al.  Studies directed to the total synthesis of ET 743 and analogues thereof: an expeditious route to the ABFGH subunit. , 2002, Organic letters.

[21]  E. Corey,et al.  Antitumor activity- and gene expression-based profiling of ecteinascidin Et 743 and phthalascidin Pt 650. , 2001, Chemistry & biology.

[22]  T. Molinski,et al.  Regioselective cationic reduction of 2-aryl-1-N-(ethoxycarbonyl)enamines to 2-arylethylamine carbamates , 2001 .

[23]  L. Hurley,et al.  Differential rates of reversibility of ecteinascidin 743-DNA covalent adducts from different sequences lead to migration to favored bonding sites. , 2001, Journal of the American Chemical Society.

[24]  A. Plowright,et al.  Synthesis and evaluation of bishydroquinone derivatives of (-)-saframycin A: identification of a versatile molecular template imparting potent antiproliferative activity. , 2001, Journal of the American Chemical Society.

[25]  F. Gago,et al.  Increased DNA binding specificity for antitumor ecteinascidin 743 through protein-DNA interactions? , 2000, Journal of medicinal chemistry.

[26]  R. Perona,et al.  CL100/MKP-1 modulates JNK activation and apoptosis in response to cisplatin , 2000, Oncogene.

[27]  F. de la Calle,et al.  Synthesis of ecteinascidin ET-743 and phthalascidin Pt-650 from cyanosafracin B. , 2000, Organic letters.

[28]  F. Gago,et al.  Bending of DNA upon Binding of Ecteinascidin 743 and Phthalascidin 650 Studied by Unrestrained Molecular Dynamics Simulations , 2000 .

[29]  M. Boyd,et al.  Antineoplastic agents 430. Isolation and structure of cribrostatins 3, 4, and 5 from the republic of maldives cribrochalina species. , 2000, Journal of natural products.

[30]  S. Danishefsky,et al.  Synthetic explorations in the saframycin-ecteinascidin series: construction of major chiral subunits through catalytic asymmetric induction , 2000 .

[31]  A. Myers,et al.  A Concise, Stereocontrolled Synthesis of (−)-Saframycin A by the Directed Condensation of α-Amino Aldehyde Precursors , 1999 .

[32]  L. Hurley,et al.  Ecteinascidin 743: a minor groove alkylator that bends DNA toward the major groove. , 1999, Journal of medicinal chemistry.

[33]  R. Mantovani,et al.  Effect of ecteinascidin-743 on the interaction between DNA binding proteins and DNA. , 1999, Anti-cancer drug design.

[34]  S. Schreiber,et al.  Phthalascidin, a synthetic antitumor agent with potency and mode of action comparable to ecteinascidin 743. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[35]  L. Hurley,et al.  Molecular Basis for the DNA Sequence Selectivity of Ecteinascidin 736 and 743: Evidence for the Dominant Role of Direct Readout via Hydrogen Bonding , 1998 .

[36]  B. Herberich,et al.  DNA Interstrand Cross-Link Formation Induced by Bioxalomycin α2 , 1998 .

[37]  R. Wheelhouse,et al.  Mechanism for the catalytic activation of ecteinascidin 743 and its subsequent alkylation of guanine N2 , 1998 .

[38]  A. Kubo,et al.  Synthesis of Novel Octahydro-1, 5-imino-3-benzazocin-4, 7, 10-trione Derivatives Having a Methyl Group at the C-2 Position as ABC Ring Models of Saframycins , 1997 .

[39]  E. Corey,et al.  Enantioselective Total Synthesis of Ecteinascidin 743 , 1996 .

[40]  Ross A. Miller,et al.  Stereocomplementary reductions of ring fused enelactams , 1995 .

[41]  M. Boyd,et al.  Some practical considerations and applications of the national cancer institute in vitro anticancer drug discovery screen , 1995 .

[42]  W. Remers,et al.  Computer simulation of the binding of saframycin A to d (GATGCATC)2. , 1991, Journal of medicinal chemistry.

[43]  Paul A. Keifer,et al.  Ecteinascidins 729, 743, 745, 759A, 759B, and 770: potent antitumor agents from the Caribbean tunicate Ecteinascidia turbinata , 1990 .

[44]  M. Morimoto,et al.  Antitumor activity of a novel antitumor antibiotic, quinocarmycin citrate (KW2152). , 1987, Cancer research.

[45]  S. Sakiyama,et al.  Binding of saframycin A, a heterocyclic quinone anti-tumor antibiotic to DNA as revealed by the use of the antibiotic labeled with [14C]tyrosine or [14C]cyanide. , 1981, The Journal of biological chemistry.

[46]  C. Avendaño,et al.  Synthesis and cytotoxic activity of pyrazino[1,2-b]-isoquinolines, 1-(3-isoquinolyl)isoquinolines, and 6,15-iminoisoquino[3,2-b]-3-benzazocines. , 2007, Bioorganic & medicinal chemistry.

[47]  H. Holland,et al.  A one-pot synthesis of tertiary amines from amines, lactams and urethanes , 1979 .

[48]  N. M. Loim,et al.  Applications of Ionic Hydrogenation to Organic Synthesis , 1974 .